GrippeCanadaV4, Main, Exploration, bibRecordById, pubmed:28335511

1st Workshop of the Canadian Society for Virology.

Identifieur interne : 000130 ( Main/Exploration ); précédent : 000129; suivant : 000131

1st Workshop of the Canadian Society for Virology.

Auteurs : Craig Mccormick [Canada] ; Nathalie Grandvaux [Canada]

Source :

Viruses [ 1999-4915 ] ; 2017.

RBID : pubmed:28335511

Descripteurs français

KwdFr :
- Canada (MeSH), Humains (MeSH), Poxviridae (physiologie), Recherche biomédicale (tendances), Recherche médicale translationnelle (tendances), Sociétés savantes (MeSH), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (isolement et purification), Virginie (MeSH), Virologie (tendances), Virus oncolytiques (physiologie), Éducation (MeSH).
MESH :
- immunologie : Vaccins antigrippaux.
- isolement et purification : Vaccins antigrippaux.
- physiologie : Poxviridae, Virus oncolytiques.
- tendances : Recherche biomédicale, Recherche médicale translationnelle, Virologie.
- Canada, Humains, Sociétés savantes, Virginie, Éducation.

English descriptors

KwdEn :
- Biomedical Research (trends), Canada (MeSH), Education (MeSH), Humans (MeSH), Influenza Vaccines (immunology), Influenza Vaccines (isolation & purification), Oncolytic Viruses (physiology), Poxviridae (physiology), Societies, Scientific (MeSH), Translational Medical Research (trends), Virginia (MeSH), Virology (trends).
MESH :
- chemical , immunology : Influenza Vaccines.
- chemical , isolation & purification : Influenza Vaccines.
- physiology : Oncolytic Viruses, Poxviridae.
- trends : Biomedical Research, Translational Medical Research, Virology.
- Canada, Education, Humans, Societies, Scientific, Virginia.

Abstract

The 1st Workshop of the Canadian Society for Virology (CSV2016) was a Special Workshop of the 35th Annual Meeting for the American Society for Virology, held on 18 June 2016 on the beautiful Virginia Tech campus in Blacksburg, Virginia. The workshop provided a forum for discussion of recent advances in the field, in an informal setting conducive to interaction with colleagues. CSV2016 featured two internationally-renowned Canadian keynote speakers who discussed translational virology research; American Society for Virology President Grant McFadden (then from University of Florida, now relocated to Arizona State University) who presented his studies of oncolytic poxviruses, while Matthew Miller (McMaster University) reviewed the prospects for a universal influenza vaccine. The workshop also featured a variety of trainee oral and poster presentations, and a panel discussion on the topic of the future of the CSV and virus research in Canada.

DOI: 10.3390/v9030054
PubMed: 28335511
PubMed Central: PMC5371809

Affiliations:

Canada

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000105
to stream Main, to step Curation: 000105

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">1st Workshop of the Canadian Society for Virology.</title>
<author><name sortKey="Mccormick, Craig" sort="Mccormick, Craig" uniqKey="Mccormick C" first="Craig" last="Mccormick">Craig Mccormick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2</wicri:regionArea>
<wicri:noRegion>NS B3H 4R2</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2</wicri:regionArea>
<wicri:noRegion>NS B3H 4R2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grandvaux, Nathalie" sort="Grandvaux, Nathalie" uniqKey="Grandvaux N" first="Nathalie" last="Grandvaux">Nathalie Grandvaux</name>
<affiliation wicri:level="1"><nlm:affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, QC H3C 3J7, Canada. nathalie.grandvaux@umontreal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Biochimie et Médecine Moléculaire, Université de Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Centre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada. nathalie.grandvaux@umontreal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9</wicri:regionArea>
<wicri:noRegion>QC H2X 0A9</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28335511</idno>
<idno type="pmid">28335511</idno>
<idno type="doi">10.3390/v9030054</idno>
<idno type="pmc">PMC5371809</idno>
<idno type="wicri:Area/Main/Corpus">000105</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000105</idno>
<idno type="wicri:Area/Main/Curation">000105</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000105</idno>
<idno type="wicri:Area/Main/Exploration">000105</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">1st Workshop of the Canadian Society for Virology.</title>
<author><name sortKey="Mccormick, Craig" sort="Mccormick, Craig" uniqKey="Mccormick C" first="Craig" last="Mccormick">Craig Mccormick</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2</wicri:regionArea>
<wicri:noRegion>NS B3H 4R2</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2</wicri:regionArea>
<wicri:noRegion>NS B3H 4R2</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Grandvaux, Nathalie" sort="Grandvaux, Nathalie" uniqKey="Grandvaux N" first="Nathalie" last="Grandvaux">Nathalie Grandvaux</name>
<affiliation wicri:level="1"><nlm:affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, QC H3C 3J7, Canada. nathalie.grandvaux@umontreal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Département de Biochimie et Médecine Moléculaire, Université de Montréal, QC H3C 3J7</wicri:regionArea>
<wicri:noRegion>QC H3C 3J7</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><nlm:affiliation>Centre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada. nathalie.grandvaux@umontreal.ca.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Centre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9</wicri:regionArea>
<wicri:noRegion>QC H2X 0A9</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Viruses</title>
<idno type="eISSN">1999-4915</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Biomedical Research (trends)</term>
<term>Canada (MeSH)</term>
<term>Education (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Influenza Vaccines (immunology)</term>
<term>Influenza Vaccines (isolation & purification)</term>
<term>Oncolytic Viruses (physiology)</term>
<term>Poxviridae (physiology)</term>
<term>Societies, Scientific (MeSH)</term>
<term>Translational Medical Research (trends)</term>
<term>Virginia (MeSH)</term>
<term>Virology (trends)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Canada (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Poxviridae (physiologie)</term>
<term>Recherche biomédicale (tendances)</term>
<term>Recherche médicale translationnelle (tendances)</term>
<term>Sociétés savantes (MeSH)</term>
<term>Vaccins antigrippaux (immunologie)</term>
<term>Vaccins antigrippaux (isolement et purification)</term>
<term>Virginie (MeSH)</term>
<term>Virologie (tendances)</term>
<term>Virus oncolytiques (physiologie)</term>
<term>Éducation (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en"><term>Influenza Vaccines</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Vaccins antigrippaux</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Poxviridae</term>
<term>Virus oncolytiques</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Oncolytic Viruses</term>
<term>Poxviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Recherche biomédicale</term>
<term>Recherche médicale translationnelle</term>
<term>Virologie</term>
</keywords>
<keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Biomedical Research</term>
<term>Translational Medical Research</term>
<term>Virology</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Canada</term>
<term>Education</term>
<term>Humans</term>
<term>Societies, Scientific</term>
<term>Virginia</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Canada</term>
<term>Humains</term>
<term>Sociétés savantes</term>
<term>Virginie</term>
<term>Éducation</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The 1st Workshop of the Canadian Society for Virology (CSV2016) was a Special Workshop of the 35th Annual Meeting for the American Society for Virology, held on 18 June 2016 on the beautiful Virginia Tech campus in Blacksburg, Virginia. The workshop provided a forum for discussion of recent advances in the field, in an informal setting conducive to interaction with colleagues. CSV2016 featured two internationally-renowned Canadian keynote speakers who discussed translational virology research; American Society for Virology President Grant McFadden (then from University of Florida, now relocated to Arizona State University) who presented his studies of oncolytic poxviruses, while Matthew Miller (McMaster University) reviewed the prospects for a universal influenza vaccine. The workshop also featured a variety of trainee oral and poster presentations, and a panel discussion on the topic of the future of the CSV and virus research in Canada.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28335511</PMID>
<DateCompleted><Year>2017</Year>
<Month>09</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2019</Year>
<Month>01</Month>
<Day>10</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>9</Volume>
<Issue>3</Issue>
<PubDate><Year>2017</Year>
<Month>03</Month>
<Day>20</Day>
</PubDate>
</JournalIssue>
<Title>Viruses</Title>
<ISOAbbreviation>Viruses</ISOAbbreviation>
</Journal>
<ArticleTitle>1st Workshop of the Canadian Society for Virology.</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E54</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/v9030054</ELocationID>
<Abstract><AbstractText>The 1st Workshop of the Canadian Society for Virology (CSV2016) was a Special Workshop of the 35th Annual Meeting for the American Society for Virology, held on 18 June 2016 on the beautiful Virginia Tech campus in Blacksburg, Virginia. The workshop provided a forum for discussion of recent advances in the field, in an informal setting conducive to interaction with colleagues. CSV2016 featured two internationally-renowned Canadian keynote speakers who discussed translational virology research; American Society for Virology President Grant McFadden (then from University of Florida, now relocated to Arizona State University) who presented his studies of oncolytic poxviruses, while Matthew Miller (McMaster University) reviewed the prospects for a universal influenza vaccine. The workshop also featured a variety of trainee oral and poster presentations, and a panel discussion on the topic of the future of the CSV and virus research in Canada.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McCormick</LastName>
<ForeName>Craig</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Beatrice Hunter Cancer Research Institute, Dalhousie University, 5850 College Street, Halifax, NS B3H 4R2, Canada. craig.mccormick@dal.ca.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Grandvaux</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Département de Biochimie et Médecine Moléculaire, Université de Montréal, QC H3C 3J7, Canada. nathalie.grandvaux@umontreal.ca.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Centre de Recherche du CHUM (CRCHUM), Montréal, QC H2X 0A9, Canada. nathalie.grandvaux@umontreal.ca.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><Agency>CIHR</Agency>
<Country>Canada</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016423">Congress</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2017</Year>
<Month>03</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Viruses</MedlineTA>
<NlmUniqueID>101509722</NlmUniqueID>
<ISSNLinking>1999-4915</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D035843" MajorTopicYN="N">Biomedical Research</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004493" MajorTopicYN="N">Education</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D050504" MajorTopicYN="N">Oncolytic Viruses</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011212" MajorTopicYN="N">Poxviridae</DescriptorName>
<QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012958" MajorTopicYN="Y">Societies, Scientific</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D057170" MajorTopicYN="N">Translational Medical Research</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014768" MajorTopicYN="N">Virginia</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014773" MajorTopicYN="N">Virology</DescriptorName>
<QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Canada</Keyword>
<Keyword MajorTopicYN="Y">antiviral drugs</Keyword>
<Keyword MajorTopicYN="Y">oncolytic viruses</Keyword>
<Keyword MajorTopicYN="Y">pathogenesis</Keyword>
<Keyword MajorTopicYN="Y">vaccines</Keyword>
<Keyword MajorTopicYN="Y">virology</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year>
<Month>03</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2017</Year>
<Month>03</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2017</Year>
<Month>03</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2017</Year>
<Month>3</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2017</Year>
<Month>3</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">28335511</ArticleId>
<ArticleId IdType="pii">v9030054</ArticleId>
<ArticleId IdType="doi">10.3390/v9030054</ArticleId>
<ArticleId IdType="pmc">PMC5371809</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Cell Microbiol. 2004 Aug;6(8):695-705</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15236637</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2005 Sep 2;309(5740):1577-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16141076</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Leukemia. 2009 Dec;23(12):2313-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">19865109</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2010 Jul;84(14):7267-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20410276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2010 Sep 16;6(9):e1001110</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20862315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2011 Mar;85(5):2342-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21177824</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Immunol Rev. 2011 Jan;239(1):99-108</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21198667</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Aug 24;477(7364):344-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21866101</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2011 Aug 24;477(7364):340-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21866103</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virology. 2011 Oct 25;419(2):72-83</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21907381</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Biol Blood Marrow Transplant. 2012 Oct;18(10):1540-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22516053</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2012;7(8):e43298</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22905251</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2013 Jan 1;207(1):98-105</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23087428</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2013;8(3):e59776</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23527266</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Transl Med. 2013 Aug 14;5(198):198ra107</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23946196</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Feb;20(2):276-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24457147</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Innate Immun. 2014;6(5):650-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24800889</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Gastroenterology. 2014 Oct;147(4):870-881.e8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25038432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2014 Sep 9;111(36):13133-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25157133</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2014 Dec;88(24):14278-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25275133</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2014 Dec;20(12):1999-2005</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25418529</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2015 Apr;89(7):3610-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25589655</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Blood. 2015 Jun 11;125(24):3778-88</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25904246</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS One. 2015 Apr 27;10(4):e0125619</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25915798</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2015 May 05;11(5):e1004838</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25941809</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Top Microbiol Immunol. 2016;392:303-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26499340</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Front Microbiol. 2015 Oct 12;6:1119</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26528267</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2016 Jan 1;351(6268):77-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26678878</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2016 Jun;22(6):1129-31</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27070501</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Opin Immunol. 2016 Oct;42:48-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27268395</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11931-11936</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27698132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Virus Evol. 2016 Feb 27;2(1):vew004</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27774297</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2016 Nov 14;6:37021</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27841315</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Trends Immunol. 2017 Jan;38(1):39-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27863906</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>PLoS Pathog. 2017 Feb 1;13(2):e1006191</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28146579</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2017 May 10;6(5):e30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28487558</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Mccormick, Craig" sort="Mccormick, Craig" uniqKey="Mccormick C" first="Craig" last="Mccormick">Craig Mccormick</name>
</noRegion>
<name sortKey="Grandvaux, Nathalie" sort="Grandvaux, Nathalie" uniqKey="Grandvaux N" first="Nathalie" last="Grandvaux">Nathalie Grandvaux</name>
<name sortKey="Grandvaux, Nathalie" sort="Grandvaux, Nathalie" uniqKey="Grandvaux N" first="Nathalie" last="Grandvaux">Nathalie Grandvaux</name>
<name sortKey="Mccormick, Craig" sort="Mccormick, Craig" uniqKey="Mccormick C" first="Craig" last="Mccormick">Craig Mccormick</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeCanadaV4/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000130 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000130 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    GrippeCanadaV4
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:28335511
   |texte=   1st Workshop of the Canadian Society for Virology.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:28335511" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a GrippeCanadaV4

This area was generated with Dilib version V0.6.35.
Data generation: Sat Aug 8 18:52:12 2020. Site generation: Sat Feb 13 16:40:04 2021

	Serveur d'exploration sur la grippe au Canada
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la grippe au Canada

1st Workshop of the Canadian Society for Virology.

1st Workshop of the Canadian Society for Virology.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki